Axactor (ACR) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
29 May, 2026Executive summary
Announced a transformational transaction with Fortress, including a EUR 200 million private placement at NOK 4.70, with EUR 175 million pre-committed by Fortress and Geveran, and a subsequent offering of up to EUR 20 million to existing shareholders.
Established a co-investment partnership with Fortress, enhancing investment capacity, underwriting capabilities, and enabling asset-light 3PC revenue growth.
Sold a EUR 200 million seed portfolio, generating EUR 100 million in proceeds, with 50.1% ownership retained and consolidation of the entity.
Issued a new EUR 100 million bond at 3m EURIBOR + 3.90%, over 50% lower than the cost of the largest outstanding bond, and 2x oversubscribed.
Transaction unlocks significant earnings growth potential through deleveraging, refinancing, and higher investment capacity.
Financial highlights
Gross revenue for Q1 2026 was EUR 75.1 million, down 3% year-over-year due to prior portfolio sales and low 2025 investment.
Group total revenue was EUR 53.4 million, down from EUR 65 million in Q1 2025, impacted by negative NPL revaluations.
Reported EBITDA was EUR 22.2 million (42% margin), with cash EBITDA at EUR 44.7 million.
Net profit after tax was EUR 1.3 million, compared to EUR 10.1 million in Q1 2025.
Operating expenses decreased by 5% year-over-year, with operating expenses as a percentage of gross revenue at 41%.
Outlook and guidance
Targets annual NPL portfolio investments of EUR 200–400 million.
Aims for 10% annual average growth in 3PC segment and ROE above 15%.
Plans to maintain leverage ratio between 2.25x and 2.75x.
Intends to distribute at least 50% of adjusted net profits to shareholders starting June 2027.
A thorough IFRS review of the NPL book is underway, with results expected by end of Q2 2026.
Latest events from Axactor
- Major equity raise and NPL revaluation drive net loss, but leverage and 3PC growth improve.ACR
Q2 2026 - Cost optimization, tech adoption, and strong growth drive efficiency and profitability.ACR
Status update - EUR 200m placement and co-investment deal to drive growth, boost capacity, and reduce leverage.ACR
Investor update - Revenue and margins improved, with strong 3PC growth and focus on deleveraging over dividends.ACR
Q4 2025 - Refinancing, strong collections, and 3PC growth support a positive outlook.ACR
Q2 2025 - Cash EBITDA up 6% to EUR 59M, but net profit and ROE to shareholders fell to 0%.ACR
Q3 2024 - Cash EBITDA up 3% to EUR 61.1M as cost control offsets 2% revenue decline.ACR
Q2 2024 - Record 12% ROE, 50% EBITDA margin, and 28% 3PC growth highlight strong Q1 results.ACR
Q1 2025 - Q4 revenue surged on a Spanish sale, but negative revaluations led to a net loss; liquidity is strong.ACR
Q4 2024